Clinically relevant parameters included IL28B polymorphism CT genotype and chronic hepatitis associated with mild activity (Ishak index 5/18) and mild-moderate portal/peri-portal fibrosis (fibrosis stage 2/6). Here, IFNL3 is linked to chronic hepatitis.